BioCentury
ARTICLE | Distillery Therapeutics

Ophthalmic disease

November 6, 2018 8:44 PM UTC

Patient sample studies suggest CRISPR-mediated editing of PRPF31 could help treat retinitis pigmentosa caused by a loss-of-function point mutation in the gene. In retinal pigment epithelium cells and ...